The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children
Clinical trial NCT06890143 · RECRUITING
Trial details
- NCT number
- NCT06890143
- Sponsor
- Children's Hospital of Fudan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-22
- Primary completion
- 2026-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.